The FDA’s approval of a biosimilar for omalizumab brings new treatment options for patients. Discover the implications and what it means for you.
Biologic drugs are developed from cells of living organisms such as humans, animals or microorganisms. The medications target specific cells, proteins and pathways that cause inflammation in the body.
10304 Eaton Place, Suite 100
Fairfax, VA 22030
Phone: 800-878-4403
Quick Links
Quick Links